Arrivent Biopharma Inc (AVBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 74,293 | 282,855 | 298,669 | 317,393 | 150,389 |
| Marketable Securities | 144,570 | N/A | N/A | N/A | N/A |
| TOTAL | $226,979 | $292,398 | $308,511 | $327,480 | $159,968 |
| Non-Current Assets | |||||
| Investments And Advances | 47,683 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 280 | 313 | 344 | 358 | 3,130 |
| TOTAL | $47,963 | $313 | $344 | $358 | $3,130 |
| Total Assets | $274,942 | $292,711 | $308,855 | $327,838 | $163,098 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,782 | 4,646 | 3,812 | 4,098 | 4,532 |
| Accrued Expenses | 13,330 | 10,359 | 8,134 | 5,732 | 6,952 |
| TOTAL | $17,274 | $15,162 | $12,098 | $9,977 | $11,624 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 14 | 56 | 98 | 138 | 177 |
| TOTAL | $14 | $56 | $98 | $138 | $177 |
| Total Liabilities | $17,288 | $15,218 | $12,196 | $10,115 | $11,801 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,016 | 33,697 | 33,586 | 33,494 | N/A |
| Common Shares | 3 | 3 | 3 | 3 | N/A |
| Retained earnings | -238,333 | -217,700 | -197,136 | -175,262 | -157,845 |
| Other shareholders' equity | -211 | 0 | 0 | 0 | 304,490 |
| TOTAL | $257,654 | $277,493 | $296,659 | $317,723 | $151,297 |
| Total Liabilities And Equity | $274,942 | $292,711 | $308,855 | $327,838 | $163,098 |